Simplex Trading’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16
Closed 9736
2022
Q4
$0 Sell
16
-136
-89% -$469 ﹤0.01% 9937
2022
Q3
$0 Buy
152
+3
+2% +$11 ﹤0.01% 10525
2022
Q2
$0 Sell
149
-230
-61% -$765 ﹤0.01% 10668
2022
Q1
$1K Buy
379
+34
+10% +$194 ﹤0.01% 10107
2021
Q4
$3K Buy
+345
New +$4.58K ﹤0.01% 9844
2021
Q2
Sell
-8,185
Closed -$216K 10453
2021
Q1
$183K Buy
8,185
+8,174
+74,309% +$187K ﹤0.01% 4879
2020
Q4
$0 Buy
+11
New +$171 ﹤0.01% 8810
2020
Q3
Sell
-136
Closed -$2K 8203
2020
Q2
$2K Sell
136
-2,769
-95% -$60.6K ﹤0.01% 7257
2020
Q1
$55K Buy
+2,905
New +$74K ﹤0.01% 5035
2019
Q4
Sell
-385
Closed -$14K 7705
2019
Q3
$19K Sell
385
-1,758
-82% -$104K ﹤0.01% 5845
2019
Q2
$169K Buy
2,143
+756
+55% +$44.9K ﹤0.01% 3639
2019
Q1
$91K Buy
+1,387
New +$81K ﹤0.01% 4440

Other funds holding MRKR

Simplex Trading's MRKR Position: Q1 2023 in Review

Simplex Trading sold out of Marker Therapeutics (MRKR) in Q1 2023, closing a stake of 16 shares.

Simplex Trading first reported a position in MRKR in Q1 2019 and held it in 12 quarters. The position peaked at $183K in Q1 2021. 30 funds tracked by Wall St. Rank hold MRKR as of Q1 2023.

  • Simplex Trading reported no remaining Marker Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 16 Marker Therapeutics shares in Q1 2023.
  • Simplex Trading first reported a position in Marker Therapeutics in Q1 2019 and held it in 12 quarters.
  • Simplex Trading's Marker Therapeutics position peaked at $183K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.